Wockhardt Ltd. is a pharmaceutical and biotechnology company headquartered in India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It is a global company with a more than half of its revenue coming from Europe. The Company has a market capitalisation of over US$ 1 billion and an annual turnover of US$ 650 million.

PropertyValue
dbpedia-owl:Company/industry
dbpedia-owl:Company/product
dbpedia-owl:Organisation/foundationDate
  • 1960-01-01 00:00:00 (xsd:date)
dbpedia-owl:Organisation/keyPerson
dbpedia-owl:Organisation/keyPersonPosition
  • Habil Khorakiwala (Chairman)
    Murtaza Khorakiwala (Managing Director)
    Huzaifa Khorakiwala (Executive Director)
dbpedia-owl:Organisation/location
dbpedia-owl:Organisation/numberOfEmployees
  • 7000 (xsd:integer)
dbpedia-owl:Organisation/revenue
  • 650000000
dbpedia-owl:Organisation/type
dbpedia-owl:foundationDate
  • 1960-01-01 00:00:00 (xsd:date)
dbpedia-owl:industry
dbpedia-owl:keyPerson
dbpedia-owl:keyPersonPosition
  • Habil Khorakiwala (Chairman)
    Murtaza Khorakiwala (Managing Director)
    Huzaifa Khorakiwala (Executive Director)
dbpedia-owl:location
dbpedia-owl:numberOfEmployees
  • 7000 (xsd:integer)
dbpedia-owl:product
dbpedia-owl:revenue
  • 650000000
dbpedia-owl:type
dbpprop:abstract
  • Wockhardt Ltd. is a pharmaceutical and biotechnology company headquartered in India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It is a global company with a more than half of its revenue coming from Europe. The Company has a market capitalisation of over US$ 1 billion and an annual turnover of US$ 650 million. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company employs over 7,000 people globally. Wockhardt Hospitals is a subsidiary of the Wockhardt Group. Wockhardt was founded by Habil Khorakiwala in the early 1960s. His father Fakhruddin T. Khorakiwala had acquired Worli Chemical Works in 1959. This was incorporated as Wockhardt Pvt. Ltd. , in 1973. Wockhardt Ltd. was incorporated on July 8.1999. Wockhardt is often confused as a multinational because of its German sounding name. Wockhardt is the first company outside of the US and Europe to manufacture recombinant human insulin. Wockhardt's acquisitions include Wallis Laboratory, UK (1998), Merind, India (1998), CP Pharmaceuticals, UK (2003), Espharma GmbH, Germanay (2004), Dumex India (2006), Pinewood Laboratory, Ireland (2006) and Negma, France (2007). Wockhardt's debt following the acquisitions was close to Rs 3,800 crore, and Habil Khorakiwala quit as Managing Director. The board of directors, on March 31, 2009 approved the appointments of Habil Khorakiwala's sons Murtaza Khorakiwala and Hozaifa Khorakiwala as Managing Director and Executive Director respectively.
dbpprop:areaServed
  • Worldwide
dbpprop:companyName
  • Wockhardt Ltd.
dbpprop:companyType
dbpprop:foundation
  • 1960s
dbpprop:founder
  • Habil Khorakiwala
dbpprop:homepage
dbpprop:industry
dbpprop:keyPeople
dbpprop:location
dbpprop:marketCap
  • $ 1 Billion
dbpprop:numEmployees
  • 7000 (xsd:integer)
dbpprop:products
dbpprop:reference
dbpprop:revenue
  • $ 650 million
dbpprop:wikiPageUsesTemplate
rdf:type
rdfs:comment
  • Wockhardt Ltd. is a pharmaceutical and biotechnology company headquartered in India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It is a global company with a more than half of its revenue coming from Europe. The Company has a market capitalisation of over US$ 1 billion and an annual turnover of US$ 650 million.
rdfs:label
  • Wockhardt
skos:subject
foaf:homepage
foaf:name
  • Wockhardt Ltd.
foaf:page